SOPHiA GENETICS
SOPH
36 hedge funds and large institutions have $81.2M invested in SOPHiA GENETICS in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
88% more capital invested
Capital invested by funds: $43.2M → $81.2M (+$38M)
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
13% more funds holding
Funds holding: 32 → 36 (+4)
0.47% more ownership
Funds ownership: 26.05% → 26.51% (+0.47%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$748K |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$463K |
| 3 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
+$223K |
| 4 |
LCM
Legato Capital Management
San Francisco,
California
|
+$187K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$150K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$160K |
| 2 |
BPC
Banque Pictet & Cie
Geneva 73,
Switzerland
|
-$150K |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$150K |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$123K |
| 5 |
JP Morgan Chase
New York
|
-$111K |
SOPH Hedge Fund Activity: Q4 2023 in Review
36 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in SOPHiA GENETICS (SOPH) for Q4 2023, worth a combined $81.2M — up 88% from $43.2M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new SOPH positions and 1 closed out — a net gain of 5 holders — while 10 added to existing stakes and 7 trimmed.
The largest buyer was Parkman Healthcare Partners, opening a new position worth an estimated $748K. The largest seller was Millennium Management, cutting an estimated $160K.
- 36 institutional investors held SOPHiA GENETICS (SOPH) as of Q4 2023, up from 32 in Q3 2023.
- Funds reported $81.2M of SOPHiA GENETICS stock for Q4 2023, up 88% quarter-over-quarter.
- 6 funds opened new SOPHiA GENETICS positions in Q4 2023 and 1 closed out, a net change of +5 holders.
- The largest SOPHiA GENETICS buyer in Q4 2023 was Parkman Healthcare Partners, an estimated $748K added.
- The largest SOPHiA GENETICS seller in Q4 2023 was Millennium Management, an estimated $160K sold.
Based on aggregated 13F filings for Q4 2023.